InsiderTrades

Form 4 for DFNS T3 Defense Inc.

Accepted 2026-01-20 00:00:00 ET · period of report 2026-01-15 · accession 0001213900-26-005839 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-01-20 2026-01-16 DFNS Shalom Menachem CEO, Dir, 10% J - Other $0.00 +1.99M 3.24M +159% $0
D 2026-01-20 2026-01-15 DFNS Shalom Menachem CEO, Dir, 10% J - Other $0.00 +5.02M 5.02M New $0
D 2026-01-20 2026-01-13 DFNS Shalom Menachem CEO, Dir, 10% A - Grant — +1.75M 1.75M New —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock$0.0001 par value per share 2026-01-16 J A 1,992,010 $0.00 3,242,010 D — — (F1) The securities were issued to the reporting person upon completion of the acquisition by Nukkleus Inc of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc. (the "Star 26") As a result of being a shareholder of Star 26, the Reporting Person received the shares and warrants reported above.
2 Derivative Common Stock Purchase Warrants 2026-01-15 J A 5,018,359 $0.00 5,018,359 D $1.50 · 2026-01-15 to 2031-01-15 5,018,359 Common (F1) The securities were issued to the reporting person upon completion of the acquisition by Nukkleus Inc of 100% of the issued and outstanding capital stock of Star 26 Capital, Inc. (the "Star 26") As a result of being a shareholder of Star 26, the Reporting Person received the shares and warrants reported above.
3 Derivative Call Option (to Purchase Common Stock and warrants) 2026-01-13 A A 1,752,593 — 1,752,593 D $1.50 · — to — — Common (F2) The Reporting Person is a party to the Call Option Agreement dated January 13, 2026 with Esousa Group Holdings LLC ("Esousa") pursuant to which the Reporting Person has the right to purchase from Esousa 498,003 shares of Common Stock and warrants to purchase 1,254,590 shares of Common Stock at a per share exercise price of $1.50. The right shall commence only after Esousa has sold a portion of said securities for gross proceeds equal to $3,000,000 (the "Satisfaction Date") and terminate upon the earlier of the parties agreeing in writing to its termination, when Esousa no longer holds the securities and 60 days after the Satisfaction Date.